Arcus Biosciences Inc.
RCUS
|
|
| |
|
| Trading Volume | 7,820 |
|
|
22.51 - 13.44 |
| Market Cap Full | $ 1.3B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 1.1% | -0.9% | -11.8% | -21.7% |
| Q2 | - | -18% | 11.3% | -20% |
| Q3 | - | 5.4% | -11.6% | 3.2% |
| Q4 | - | -16.7% | 10.5% | -20.9% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.1 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -20.7 | 26.4 | -1.1 | -22.5 | 2.7 | 0.8 | 8.3 | 5.4 | - | - | - | -3.5 |
| 2023 | |||||||||||
| 4.5 | -15.8 | 0.3 | -2.2 | 15.1 | -1.1 | -2 | 2.9 | -12.4 | -12.5 | -4.1 | 26.8 |
| 2022 | |||||||||||
| -23.9 | 20.8 | -14.8 | -23.6 | -21.7 | 33.7 | 4.3 | -8.9 | 8.6 | -2.6 | 38 | -41.2 |
| 2021 | |||||||||||
| 34.5 | 1 | -20.7 | 20.8 | -26.7 | 11 | 14.4 | -7.1 | 19.5 | -4.1 | 26.5 | -4.3 |
| 2020 | |||||||||||
| -11.3 | 70.7 | -8.8 | 90.3 | 18.7 | -21.1 | -20.5 | 19.8 | -27.3 | 26.6 | 25.5 | -4.7 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -1.1 | -1 | -1.1 | -0.6 |
| Q2 | -1 | -0.9 | -1.1 | -0.9 |
| Q3 | -0.9 | -0.9 | -1.1 | 0 |
| Q4 | 0 | -0.9 | 4 | -0.7 |
| A | -3.07 | -3.7 | 0.7 | -2.2 |